Clinical Trials Directory

Trials / Completed

CompletedNCT04941001

Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS)

Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS) in Primary Care Using a Digital Consultation Tool During the COVID-19 Pandemic

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
202 (actual)
Sponsor
Guy's and St Thomas' NHS Foundation Trust · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

A digital tool, called ReferID has been developed to facilitate the review of asthma patients. It aims to assist in the identification of patients with uncontrolled and/or severe asthma and to ensure a timely referral to secondary care where appropriate. To validate the tool, patients will be randomised to have a review with a healthcare professional using tool to facilitate the review or to continue receiving usual care. Outcome measures including exacerbation frequency and level of asthma control will be assessed at 12 months.

Conditions

Interventions

TypeNameDescription
DEVICEReferIDThe ReferID tool is a digital tool which can be used to facilitate a review of asthma in primary care

Timeline

Start date
2021-08-09
Primary completion
2023-02-01
Completion
2023-02-01
First posted
2021-06-28
Last updated
2023-08-28

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04941001. Inclusion in this directory is not an endorsement.